The clinical development of new mitotic inhibitors that stabilize the microtubule
Microtubule-stabilizing agents are increasingly studied for cancer treatment based largely on the prior success of paclitaxel and docetaxel. In this review, we focus on the clinical development of epothilones and discodermolide, and we discuss salient preclinical and clinical highlights of these two...
Saved in:
Published in | Anti-cancer drugs Vol. 15; no. 6; p. 553 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.07.2004
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!